Results 101 to 110 of about 3,591 (202)

A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab

Therapeutics and Clinical Risk Management, 2016
Mary Lou Affronti,1–3 Sarah Woodring,1,2 Katherine B Peters,1,4 James E Herndon II,5 Frances McSherry,5 Patrick N Healy,5 Annick Desjardins,1,4 James J Vredenburgh,6 Henry S Friedman1,2 1The Preston Robert Tisch Brain Tumor Center at Duke ...
Affronti ML, Woodring S, Peters KB, Herndon II JE, McSherry F, Healy PN, Desjardins A, Vredenburgh JJ, Friedman HS   +8 more
doaj  

PENGARUH KECEMASAN TERHADAP KEJADIAN CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) Pengamatan pada pasien kanker payudara stadium awal dengan kemoterapi berbasis antrasiklin

, 2013
Background : Chemotherapy induced nausea and vomiting (CINV) is the most troubling adverse effects of cancer treatment that patients cite most often. Despite significant advances in understanding CINV management, nausea and vomiting are still considered ...
, Ahmad Faisal, , dr. Agus Siswanto., SpPD-KPsi.   +1 more
core  

Efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients with gastrointestinal and colorectal cancers.

, 2016
222 Background: Rolapitant (VARUBI) is a selective, long-acting neurokinin-1 receptor antagonist (RA) for the prevention of CINV. Rolapitant effectively prevented CINV in phase 3 trials of patients (pts) receiving highly or moderately emetogenic ...
Daniel Powers, Martin Chasen, Bernardo Leon Rapoport, Ian D. Schnadig, Lee Steven Schwartzberg, Karin Jordan, Sujata Arora, Rudolph M. Navari   +7 more
core   +1 more source

Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) — a systematic review and network meta-analysis

Introduction Olanzapine is an established antiemetic for the prevention of chemotherapy-induced nausea and vomiting (CINV), although the optimal dose for balancing efficacy and tolerability remains uncertain. We conducted a systematic
on behalf of the MASCC Antiemetic Study Group, Daniel Zhang, Christina H. Ruhlmann, Monica Yuen, Michael Lock, Mary Louise Affronti, Matti Aapro, Paul J. Hesketh, Victoria Fortuna, Gabriel Boldt, Florian Scotté, Angel Lu, Sumeet Talwar, Lawson Eng, Hirotoshi Iihara, Jennifer Leigh, Gregory W. Chai, Mitsue Saito, Shing Fung Lee, Ronald Chow   +19 more
core   +1 more source

Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study

Chemotherapy-induced nausea and vomiting (CINV) is a challenging adverse effect that is associated with deteriorating quality of life. Inhibiting neurokinin 1 and 5-hydroxytryptamine type 3 receptors involved in the major emesis pathways has ...
Mamatha Madavi, Anjani Devi Musinipally, Ramakrishna Kancha, Sowmya Dayyala, Lavanya Guram, Soumya Simhadri, Krishna Chaitanya Puligundla   +6 more
core   +1 more source

Efficacy of multimodal symptom management strategies for chemotherapy-induced nausea and vomiting in gynecologic cancer: a meta-analysis. [PDF]

Am J Cancer Res
Zhou W, Chen M, Wang T, Zhang L.
europepmc   +1 more source

Baseline neutrophil-to-lymphocyte ratio is not associated with chemotherapy-induced nausea and vomiting in patients with breast cancer: A single-center retrospective cohort study. [PDF]

Exp Ther Med
Cekin R, Dogan A.
europepmc   +1 more source

sj-txt-1-hpx-10.1177_00185787241231739 – for Trial Sequential Analysis and Meta-Analysis of Olanzapine in Pediatric Patients for Chemotherapy-Induced Nausea and Vomiting (CINV)

sj-txt-1-hpx-10.1177_00185787241231739 for Trial Sequential Analysis and Meta-Analysis of Olanzapine in Pediatric Patients for Chemotherapy-Induced Nausea and Vomiting (CINV) by Alok Singh, Dhyuti Gupta, Pankaj Kumar Kannauje and Amit Kumar Agrawal in ...
Pankaj Kumar Kannauje (17983114), Dhyuti Gupta (16508682), Amit Kumar Agrawal (17983117), Alok Singh (1871617)   +3 more
core   +1 more source

A Multi-Disciplinary Approach to the Management of Chemotherapy-Induced Nausea and Vomiting in Breast Cancer. [PDF]

Ther Clin Risk Manag
Chen F, Cao K, Zhao X, Xia L, Liu M, Jiang Y.   +5 more
europepmc   +1 more source

Pengaruh Profil Pasien Kanker yang Mendapat Kemoterapi dengan Chemotherapy Induced Nausea And Vomiting (CINV)

Purpose: This study aimed to examine the effect of cancer patient profiles receiving chemotherapy on Chemotherapy-Induced Nausea and Vomiting (CINV).
Quiambao, B. D. (Bernadette), Rahayu, N. W. (Novi), Kardiyudiani, N. K. (Ni), Indriyani, S. (Sita), Afrida, M. (Maryudella)   +4 more
core